American Airlines Reaffirms Profit Forecast Despite Rising Fuel Expenses South Bow Signals Need for Secure US Permit Before Considering Keystone XL Pipeline Restart Divis Laboratories Q4 Results Net Profit Rises 13 to Rs 751 Crore Revenue Up 10 Company Declares Rs 30 Dividend High Court Criticizes UOB Over Inconsistent Legal Positions on Mortgage Charges ADP Private Payrolls Top Expectations in April Signaling Stable Labor Market Dating Startups Target Fake Profiles as Verification Technology Gains Traction Payoneer Global Inc PAYO Q1 2026 Earnings EPS Beat Delivers 32 Surprise Amid Revenue Disclosures LH Q1 2026 Earnings Labcorp Beats EPS Estimates but Stock Slips Slightly MLAB Q1 2026 Earnings Earnings Per Share Surges Past Estimates by Over 130 HBIO Q1 2026 Earnings NarrowerThanExpected Loss Boosts Shares by 176 Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by 416 as Stock Edges Higher Kazia Therapeutics Q1 2026 Earnings A WiderThanExpected Loss Yet Shares Gain Ground Apex Treasury Corporation APXT Holds Steady Near Resistance as Trading Volume Remains Moderate VTEX VTEX Holds Steady at 358 Amidst Consolidation Near Key Support New Oriental Education EDU Edges Lower Amid Sector Headwinds BlackBerry Limited BB Surges Nearly 19 as Volume Spikes Oceaneering International OII Edges Higher as Stock Nears Key Support Zone Knowledge Realty Trust Plans Rs 700 Crore Investment for 14 Million Sq Ft Office Development in Bengaluru ECX Q1 2026 Earnings Significant EPS Miss Amid Challenging Operating Environment Deckers Outdoor DECK Gains 377 as Momentum Builds Toward Key Resistance TVACU Holds Steady at 1075 as SPAC Units Trade Flat Superior Group of Companies SGC Pulls Back Support Test in Play After 19 Decline Lakeside Holding Limited LSH Inches Higher in Tight Range AGNCL Holds Near 2484 Amid Modest Decline Preferred Stock Maintains Stability Georgia Power Preferred GPJA Rises Modestly as FixedIncome Appeal Remains in Focus Telefonica Brasil VIV Slides 09 as Telecom Sector Faces Mixed Signals Key Levels in Focus Kymera Therapeutics KYMR Holds Near Resistance After Marginal Decline